Finanzwire Finanzwire
Basculer en Français
10551 Companies
222941 Keywords
152036 Articles
117979 Press releases
Headlines Articles Press releases Secarna Pharmaceuticals GmbH & Co. KG Remove
  1. Home
  2. Companies
  3. Secarna Pharmaceuticals GmbH & Co. KG
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 11/03/2023 at 18:05, 2 years 7 months ago

    Secarna Pharmaceuticals presents data at SITC demonstrating the potential of antisense oligonucleotides in targeting NRP1

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 10/25/2023 at 15:00, 2 years 7 months ago

    Secarna Pharmaceuticals presents data at OTS showcasing unique characteristics and factors with a role in the activity and side effect profile of LNA-modified ASOs

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 10/17/2023 at 14:00, 2 years 7 months ago

    Secarna Pharmaceuticals to present two posters showcasing the innovation potential of the LNAplus platform at the 19th Annual Meeting of the Oligonucleotide Therapeutic Society

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 07/06/2023 at 14:00, 2 years 11 months ago

    Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in debilitating autoinflammatory diseases

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 06/05/2023 at 14:00, 3 years ago

    Secarna Pharmaceuticals announces publication of new preclinical data showing durable antitumor activity of LNAplus™-based ASOs that both stimulate the innate immune system and suppress PD-L1 expressi

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
  • PRESS RELEASE

    published on 03/27/2023 at 16:04, 3 years 2 months ago

    Secarna Pharmaceuticals and SciNeuro Pharmaceuticals enter into research and option agreement in the field of CNS diseases

    Logo of Secarna Pharmaceuticals GmbH & Co. KG
Previous page
1 ... 3 4
Accesswire
  • Published on 06/11/2026 at 02:45, 3 hours 34 minutes ago

    Drilling Completed at High-Grade Tolmer Silver Discovery

  • Published on 06/11/2026 at 02:35, 3 hours 44 minutes ago

    Panther Minerals Announces Appointment of Harrison Glancy to Board of Directors

  • Published on 06/11/2026 at 02:00, 4 hours 19 minutes ago

    CANEX Acquires 100% of Gold Basin Resources

  • Published on 06/11/2026 at 02:00, 4 hours 19 minutes ago

    Gold Basin Resources Announces Completion of Arrangement with CANEX

  • Published on 06/11/2026 at 01:55, 4 hours 24 minutes ago

    Pathfinder Ventures Inc. Provides Update on Revoked Cease Trade Order and Trading Reinstatement Process

View all ACCESSWIRE
EQS Group
  • Published on 06/10/2026 at 23:56, 6 hours 22 minutes ago

    EQS-Adhoc: HUGO BOSS AG: HUGO BOSS informs about unsolicited voluntary takeover offer by Frasers Group plc

  • Published on 06/10/2026 at 22:05, 8 hours 14 minutes ago

    Ridgewood Infrastructure Acquires Dauntless Air, Premier Provider of Emergency Management Infrastructure

  • Published on 06/10/2026 at 21:45, 8 hours 34 minutes ago

    EQS-Adhoc: MAHLE has successfully priced the issuance of additional EUR 200 million notes due 2032 and is launching a partial tender offer for its outstanding notes due 2028

  • Published on 06/10/2026 at 20:11, 10 hours 7 minutes ago

    EQS-Adhoc: EDAG Engineering Group AG: Board of Directors resolves on capital measures to strengthen capital base

  • Published on 06/10/2026 at 18:39, 11 hours 39 minutes ago

    EQS-Adhoc: Kontron AG: Ad hoc announcement / Ennoconn Corporation intends to launch a mandatory takeover offer to Kontron AG shareholders

View all EQS
Les Echos
  • Published on 06/10/2026 at 18:29, 11 hours 49 minutes ago

    ICADE – PR – OUTCOME OF THE COMBINED GENERAL MEETING HELD ON JUNE 10 2026

  • Published on 06/10/2026 at 17:59, 12 hours 19 minutes ago

    CDA - STGM has received € 127 million

  • Published on 06/10/2026 at 17:40, 12 hours 39 minutes ago

    Report on share repurchases from 3 to 9 June 2026

  • Published on 06/10/2026 at 07:00, 23 hours 19 minutes ago

    Acceleration of Museum Studio's international expansion

  • Published on 06/09/2026 at 19:30, 1 day 10 hours ago

    MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy